Abstract
Sera from seven patients with myasthenia gravis and from six control subjects were tested for the presence of anti-acetylcholine receptor antibodies and for the ability to reduce acetylcholine sensitivity of embryonic chick skeletal muscle cells in culture. Anti-receptor antibodies were found in all but one of the myasthenic samples and in none of the control samples. The average reduction in sensitivity caused by the myasthenic sera was 89±4%, compared with an average reduction of 15±7% caused by the control sera. A sample taken from a patient during myasthenic crisis was found to have less blocking activity and less anti-receptor antibody than a sample from the same patient after recovery.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Albuquerque E. X., Lebeda F. J., Appel S. H., Almon R., Kauffman F. C., Mayer R. F., Narahashi T., Yeh J. Z. Effects of normal and myasthenic serum factors on innervated and chronically denervated mammalian muscles. Ann N Y Acad Sci. 1976;274:475–492. doi: 10.1111/j.1749-6632.1976.tb47709.x. [DOI] [PubMed] [Google Scholar]
- Anwyl R., Appel S. M., Narahashi T. Myasthenia gravis serum reduces acetylcholine sensitivity in cultured rat myotubes. Nature. 1977 May 19;267(5608):262–263. doi: 10.1038/267262a0. [DOI] [PubMed] [Google Scholar]
- Barkas T., Harrison R., Lunt G. G., Watson C. M., Harvey A. L., Robertson J. G. Development of transient myasthenia-like symptoms in chickens injected with acetylcholine receptor from Torpedo marmorata [proceedings]. Biochem Soc Trans. 1978;6(3):634–636. doi: 10.1042/bst0060634. [DOI] [PubMed] [Google Scholar]
- Bevan S., Kullberg R. W., Heinemann S. F. Human myasthenic sera reduce acetylcholine sensitivity of human muscle cells in tissue culture. Nature. 1977 May 19;267(5608):263–265. doi: 10.1038/267263a0. [DOI] [PubMed] [Google Scholar]
- Harvey A. L., Dryden W. F. Depolarization, desensitization and the effects of tubocurarine and neostigmine in cultured skeletal muscle. Eur J Pharmacol. 1974 Jun;27(1):5–13. [PubMed] [Google Scholar]
- Lindstrom J. M., Lambert E. H. Content of acetylcholine receptor and antibodies bound to receptor in myasthenia gravis, experimental autoimmune myasthenia gravis, and Eaton-Lambert syndrome. Neurology. 1978 Feb;28(2):130–138. doi: 10.1212/wnl.28.2.130. [DOI] [PubMed] [Google Scholar]
- Lindstrom J. An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravis. Clin Immunol Immunopathol. 1977 Jan;7(1):36–43. doi: 10.1016/0090-1229(77)90027-7. [DOI] [PubMed] [Google Scholar]
- Urbaniak S. J., Penhale W. J., Irvine W. J. Circulating lymphocyte subpopulations in Hashimoto thyroiditis. Clin Exp Immunol. 1973 Nov;15(3):345–354. [PMC free article] [PubMed] [Google Scholar]
- de Crousaz G., Fulpius B. W. Increased uptake of acetylcholine-receptor antibody at motor endplate in myasthenic exacerbation. Lancet. 1978 Jan 7;1(8054):47–47. doi: 10.1016/s0140-6736(78)90396-3. [DOI] [PubMed] [Google Scholar]